Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAPEF.L Regulatory News (APEF)

  • There is currently no data for APEF

Unaudited Interim Management Statement

17 Feb 2010 15:19

RNS Number : 3009H
Bramdean Alternatives Limited
17 February 2010
 



Bramdean Alternatives Limited

Unaudited Interim Management Statement - 3 months to 31 December 2009

 

To the shareholders of Bramdean Alternatives Limited

This interim management statement has been produced solely to provide additional information to shareholders as a body to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied upon by any other party or for any other purpose.

 

This interim management statement relates to the period from 1 October 2009 to 31 December 2009, and contains information that covers this period, and up to the date of publication of this interim management statement, unless otherwise specified.

 

Overview

Bramdean Alternatives Limited ("the Company") is a Guernsey closed-ended investment company listed on the London Stock Exchange. The Company invests in a diversified portfolio of Private Equity Funds, Hedge Funds and other Specialty Funds.

 

Investment objective

To generate long term capital gains primarily through investment in a diversified portfolio of private equity funds, hedge funds and other specialty funds.

 

Material events

 

On 19 November 2009, the Company announced the appointment of Aberdeen Asset Managers Limited as its investment manager in place of Bramdean Asset Management LLP. Aberdeen will be assuming responsibility for management of the entire portfolio.

 

On 26 November 2009, certain holders of Shares in the Company owning Sterling Shares elected to switch into US Dollar Shares and certain holders of Shares in the Company owning US Dollar Shares elected to switch into Sterling Shares on the basis of the net asset value of the Company's Shares as at 30 October 2009.

 

As a result of the switch, 76,500 Sterling Shares were converted into 131,673 new US Dollar Shares and 321,790 US Dollar Shares were converted into 186,962 new Sterling Shares. Accordingly, the total voting rights in the Company changed to 261,797,331 following the conversion.

 

These elections were approved by the Board of Directors on 19 November 2009 and took effect on 26 November 2009.

 

On 23 December 2009 the Board announced the appointment of Jennifer L Wick, Philip Hebson, David Staples and Howard Myles as non-executive directors of the Company with immediate effect.

 

General description of Company's financial position as at 31 December 2009

 

Sterling shares NAV

82.33 pence

US Dollar shares NAV

US$ 0.7724

Market Capitalisation

£72.7 million

 

As described in the Company's prospectus, and as has been the case since its launch, the net asset value ("NAV") and the NAV per share are both calculated monthly by the Company's administrator based on the latest published NAV for each underlying fund.

 

With only one exception, investments in underlying funds for the month ended 31 December 2009 are valued using the values (whether final or estimated) as advised by their managers, general partners or administrators. The Company therefore relied on valuation and reporting methods used by the managers, general partners or administrators of the underlying funds in deriving the 31 December 2009 NAV and NAV per share. That exception was Aarkad and was valued at a level recommended by the Company's Investment Manager (see investment commentary, below).

 

Investment Commentary

The Company remains committed to 16 Private Equity funds, with commitments totalling US$215.3 million. No new commitments were made during the quarter. The total drawn down on commitments made is approximately US$115.5m, with 23 capital calls having been made in the quarter, totalling US$10.7 million. The Company has received total distributions of US$5.6 million since inception, with US$1.4 million received during the quarter. Revaluations were received from all of the managers during the quarter, 12 were upwards revaluations and 4 were downwards revaluations.

 

The portfolio holds two specialty funds, one of which, Aarkad, remains suspended. Following a substantial analysis of this holding we have written its valuation down by 75%. This is based on ongoing sales of underlying 'called up' assets realising considerably lower proceeds than might have been expected when referenced to the original loan value on those underlying assets. Please note that Aarkad has been reclassified by Aberdeen, from a Transitional Fund, to a Specialty Fund.

 

The Strategic Hedge Funds portfolio was down for the quarter. Our multi-strategy manager, Deephaven, registered a substantial loss based on a potential tax liability that could arise from historical trades in Spain and Australia. The markdown was initially conservative and this has been subsequently reduced.

 

The portfolio's commitment cover which includes cash and the strategic hedge funds was 89.1% at 31 December 2009.

 

Portfolio Highlights

 

Geographical Allocation

North America 77.2%

Europe 12.6%

Global 7.1%

Asia & Other 3.1%

 

Portfolio Holdings Asset Allocation

Cash 39.0%

Private Equity Funds 49.1%

Specialty Funds 2.2%

Strategic Hedge Funds 9.7%

 

 

Portfolio Holdings (Invested Capital) on 31 December 2009

 

Manager

Type

Portfolio Weighting

Cash

Cash

39.0%

Oaktree OCM Opportunities Fund VIIb LP

Private Equity

8.9%

Greenpark International Investors III LP

Private Equity

6.5%

D.E. Shaw Oculus International Members Interest

Strategic Hedge Funds

4.6%

Thomas H Lee Parallel Fund VI LP

Private Equity

3.8%

Coller International Partners V LP

Private Equity

3.7%

SVG Strategic Recovery Fund II LP

Private Equity

3.6%

MatlinPatterson Global Opportunities Partners III LP

Private Equity

3.2%

HIG Bayside Debt & LBO Fund II LP

Private Equity

2.8%

Paulson Advantage Plus Ltd

Strategic Hedge Funds

2.6%

DFJ Athena LP

Private Equity

2.6%

Silver Lake Partners III LP

Private Equity

2.5%

Tenaya Capital V LP

Private Equity

2.3%

Goldman Sachs Capital Partners VI LP

Private Equity

2.2%

Terra Firma Capital Partners III LP

Private Equity

2.2%

King Street Capital Ltd

Strategic Hedge Funds

1.8%

Pine Brook Capital Partners LP

Private Equity

1.5%

Thoma Bravo Fund IX LP

Private Equity

1.4%

Resonant Music LP

Specialty

1.4%

Rho Ventures VI LP

Private Equity

1.0%

AIG Brazil Special Situations II LP

Private Equity

0.9%

Aarkad Plc

Specialty

0.8%

Deephaven Global Multi-Strategy Fund Ltd

Strategic Hedge Funds

0.7%

 

 

Cash: The Company currently has six approved cash deposit accounts.

Transitional Investments: The Company will seek to avoid return dilution caused by holding amounts that are not committed or are committed, but not yet drawn-down, on both underlying private equity funds and underlying specialty funds by investing such amounts in a range of transitional investments, which may include equity hedge, senior debt, mezzanine and market neutral funds.

Strategic Hedge Funds: The part of the Company's portfolio managed by Man Investments (CH) AG. 

 

 

Key Facts

Market Capitalisation

£72.7 million

Investment Manager

Aberdeen Asset Managers Limited

Annual Management Fee

1.5%

Performance fee

10% subject to an 8% return and a high watermark

Company Brokers

Matrix Corporate Capital LLP

JPMorgan Cazenove

Sterling class share price on 31 December 2009

52.00 pence

Number of Sterling shares in issue

90.825 million

US Dollar class share price on 31 December 2009

US$ 0.525

Number of US Dollar shares in issue

78.384 million

NAV publication

Monthly

December Sterling Estimated NAV per share

82.33 pence

December US Dollar Estimated NAV per share

US$ 0.7724

Total December Estimated Net Asset Value

US$ 181,297,723.88

Half-year end

30 September

Financial year end

31 March

Company Secretary and Administrator

RBC Offshore Fund Managers Limited

Registrar

Capita Registrars (Guernsey) Limited

Stock Exchange code (Sterling shares)

BRAL

Stock Exchange code (U.S. Dollar shares)

BRAU

Sedol code (Sterling shares)

B1XCHB9

Sedol code (U.S. Dollar shares)

B1XCLF1

ISIN code (Sterling shares)

GG00B1XCHB94

ISIN code (US Dollar shares)

GG00B1XCLF11

 

 

Cumulative performance (%) (GBP)

 

as at

1 month

3 months

6 months

1 year

31/12/2009

Share Price

52.0

4.0

-2.8

1.5

18.9

NAV

82.3

-1.9

-4.4

3.9

-17.5

 

 

Cumulative performance (%) (USD)

 

as at

1 month

3 months

6 months

1 year

31/12/2009

Share Price

0.5

-11.7

-11.7

-11.7

-44.2

NAV

0.8

-3.6

-3.5

1.7

-5.7

 

 

Discrete performance (%) (GBP)

 

31/12/2009

31/12/2008

Share Price

18.9

-52.7

NAV

-17.5

0.4

 

Discrete performance (%) (USD)

 

31/12/2009

31/12/2008

Share Price

-44.2

-6.9

NAV

-5.7

-17.3

 

Total Return; NAV to NAV, Net Income Reinvested, GBP

Source: Aberdeen Asset Managers Limited and Morningstar

NAV returns based on NAVs excluding income and with debt valued at par

 

 

The Board is not aware of any significant events or transactions which have occurred between 1 January 2010 and the date of publication of this interim management statement which would have a material impact on the financial position of the Company. For latest performance information, please refer to the Company's website, www.invtrusts.co.uk/bramdean.

 

Please note that past performance is not necessarily a guide to the future and that the value of investments and the income from them may fall as well as rise. Investors may not get back the amount they originally invested.

 

For Bramdean Alternatives Limited

RBC Offshore Fund Managers LimitedSecretary

17 February 2010

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGGUMGPUPUGAM
Date   Source Headline
15th Sep 20172:00 pmRNSResult of AGM
1st Sep 20173:54 pmRNSPortfolio Listing, July 2017
30th Aug 20171:24 pmRNSNet Asset Value, July 2017
27th Jul 20174:29 pmRNSPortfolio Listing, June 2017
26th Jul 201711:56 amRNSNet Asset Value, June 2017
12th Jul 20177:00 amRNSPosting of Annual Report and AGM Notice
7th Jul 20173:45 pmRNSPortfolio Listing, May 2017
4th Jul 20173:28 pmRNSNet Asset Value, May 2017
26th Jun 20174:05 pmRNSAnnual Financial Report
26th Jun 201711:21 amRNSPortfolio Listing, April 2017
23rd Jun 201710:01 amRNSHolding(s) in Company
23rd Jun 20179:50 amRNSHolding(s) in Company
21st Jun 20174:35 pmRNSHolding(s) in Company
14th Jun 20172:00 pmRNSNet Asset Value, April 2017
12th Jun 20173:54 pmRNSHolding(s) in Company
19th May 20174:59 pmRNSCompliance with Market Abuse Regulations
10th May 201712:11 pmRNSPortfolio Listing, March 2017
5th May 20171:57 pmRNSNet Asset Value, March 2017
26th Apr 20172:11 pmRNSHolding(s) in Company
25th Apr 20174:01 pmRNSHolding(s) in Company
21st Apr 20173:19 pmRNSHolding(s) in Company
21st Apr 20171:23 pmRNSHolding(s) in Company
3rd Apr 20175:01 pmRNSPortfolio Listing, February 2017
30th Mar 20177:00 amRNSNet Asset Value, February 2017
21st Mar 20179:51 amRNSDirector/PDMR Shareholding
15th Mar 20171:19 pmRNSDirector/PDMR Shareholding
2nd Mar 20179:19 amRNSPortfolio Listing, January 2017
27th Feb 20179:25 amRNSNet Asset Value, January 2017
1st Feb 20174:25 pmRNSPortfolio Listing, December 2016
27th Jan 20177:00 amRNSNet Asset Value(s)
23rd Dec 201612:00 pmRNSPortfolio Listing, November 2016
23rd Dec 201610:29 amRNSNet Asset Value, November 2016
20th Dec 20162:15 pmRNSPosting of Half Year Report
12th Dec 20164:55 pmRNSDividend Declaration - Correction
9th Dec 20167:05 amRNSAppointment of Broker
9th Dec 20167:00 amRNSHalf-year Report
2nd Dec 20163:47 pmRNSPortfolio Update
1st Dec 201612:35 pmRNSNet Asset Value, October 2016
4th Nov 20165:08 pmRNSProhibited Period Announcement
25th Oct 20164:07 pmRNSPortfolio Listing, September 2016
25th Oct 201611:37 amRNSDirector Declaration
25th Oct 201611:32 amRNSNet Asset Value, September 2016
4th Oct 20163:32 pmRNSPortfolio Listing, August 2016
3rd Oct 20163:57 pmRNSNet Asset Value - August 2016
21st Sep 20162:11 pmRNSDirector/PDMR Shareholding
13th Sep 201611:52 amRNSResult of AGM
25th Aug 20163:29 pmRNSPortfolio Listing, July 2016
24th Aug 20169:51 amRNSNet Asset Value(s)
28th Jul 201610:48 amRNSPortfolio Listing, June 2016
28th Jul 20167:00 amRNSNet Asset Value, June 2016

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.